These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20561442)

  • 1. [Effect of bortezomib on VEGF gene expression of endothelial cell line HMEC-1 and its possible mechanisms].
    Xue LX; Jiang M; Xie LQ; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):744-8. PubMed ID: 20561442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors.
    Birle DC; Hedley DW
    Cancer Res; 2007 Feb; 67(4):1735-43. PubMed ID: 17308115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of bortezomib on migration of endothelial cells and angiogenesis].
    Xue LX; Jiang M; Xie LQ; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):403-6. PubMed ID: 21122357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
    Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
    Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1alpha C-terminal activation domain.
    Kaluz S; Kaluzová M; Stanbridge EJ
    Mol Cell Biol; 2006 Aug; 26(15):5895-907. PubMed ID: 16847340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells.
    Duyndam MC; van Berkel MP; Dorsman JC; Rockx DA; Pinedo HM; Boven E
    Biochem Pharmacol; 2007 Jul; 74(2):191-201. PubMed ID: 17498666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α.
    Kim YJ; Lee HJ; Kim TM; Eisinger-Mathason TS; Zhang AY; Schmidt B; Karl DL; Nakazawa MS; Park PJ; Simon MC; Yoon SS
    Int J Cancer; 2013 Jan; 132(1):29-41. PubMed ID: 22684860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.
    Dungwa JV; Hunt LP; Ramani P
    BMC Cancer; 2011 Sep; 11():390. PubMed ID: 21910893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of carbonic anhydrase IX in craniopharyngiomas.
    Proescholdt M; Merrill M; Stoerr EM; Lohmeier A; Dietmaier W; Brawanski A
    J Neurosurg; 2011 Oct; 115(4):796-801. PubMed ID: 21761968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.
    Cooper C; Liu GY; Niu YL; Santos S; Murphy LC; Watson PH
    Clin Cancer Res; 2004 Dec; 10(24):8720-7. PubMed ID: 15623657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma.
    Sung FL; Hui EP; Tao Q; Li H; Tsui NB; Lo YM; Ma BB; To KF; Harris AL; Chan AT
    Cancer Lett; 2007 Aug; 253(1):74-88. PubMed ID: 17320280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1.
    Takacova M; Holotnakova T; Barathova M; Pastorekova S; Kopacek J; Pastorek J
    Oncol Rep; 2010 Mar; 23(3):869-74. PubMed ID: 20127031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.
    Jubb AM; Pham TQ; Hanby AM; Frantz GD; Peale FV; Wu TD; Koeppen HW; Hillan KJ
    J Clin Pathol; 2004 May; 57(5):504-12. PubMed ID: 15113858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer.
    Mackay H; Hedley D; Major P; Townsley C; Mackenzie M; Vincent M; Degendorfer P; Tsao MS; Nicklee T; Birle D; Wright J; Siu L; Moore M; Oza A
    Clin Cancer Res; 2005 Aug; 11(15):5526-33. PubMed ID: 16061869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of hypoxia-inducible factor inhibitor on expression of HIF-1alpha and VEGF and induction of apoptosis in leukemic cell lines].
    Wang F; Chen BA; Cheng J; Xu WL; Wang XM; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Bao W; Song HH; Gao F; Zhang W; Xia GH; Pei XP; Wu WW; Yin L; Shan XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):74-8. PubMed ID: 20137122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-1α mRNA: a new target for destabilization by tristetraprolin in endothelial cells.
    Chamboredon S; Ciais D; Desroches-Castan A; Savi P; Bono F; Feige JJ; Cherradi N
    Mol Biol Cell; 2011 Sep; 22(18):3366-78. PubMed ID: 21775632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of hypoxia-induced transcription in normoxia.
    Hägg M; Wennström S
    Exp Cell Res; 2005 May; 306(1):180-91. PubMed ID: 15878343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.
    Kaluzová M; Kaluz S; Lerman MI; Stanbridge EJ
    Mol Cell Biol; 2004 Jul; 24(13):5757-66. PubMed ID: 15199132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.